Center for Medicinal Cannabis Research
Center for Medicinal Cannabis Research
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| THC Effects on Glucose in Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 1 | 2026-06-15 | NCT05322213 | |
| AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT) | Anorexia, Chemically-Induced Disorders, Drug Abuse, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, agnosia, nervous system disorder, perceptual disorders, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 | 2026-03-20 | NCT04859296 | |
| Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder | Recruiting | Phase 3 | 2026-01-08 | NCT04411225 | |
| Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity | Cannabis Use; HIV | Active, not recruiting | Phase 2 | 2025-10-15 | NCT04800159 | |
| Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism | autism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2025-09-30 | NCT04517799 | |
| The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol | Chemically-Induced Disorders, Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cannabis dependence, chronic renal failure syndrome, kidney disorder, kidney failure, psychiatric disorder, substance-related disorder, urinary system disorder | Active, not recruiting | Phase 1 | 2024-11-20 | NCT05742724 |